title: Vitamin D, innate immunity and outcomes in community acquired pneumonia

authors: Leow, Leong

subjects: Vitamin D

abstract: We investigated the associations between vitamin D status, the antimicrobial peptides cathelicidin and beta defensin-2 and outcomes in community acquired pneumonia. In hospitalised patients with community acquired pneumonia, vitamin D deficiency but not antimicrobial peptide levels were associated with increased 30-day mortality. Vitamin D was not associated with levels of the antimicrobial peptide cathelicidin or beta defensin-2.

text: Vitamin D, innate immunity and outcomes in community acquired pneumonia We investigated the associations between vitamin D status, the antimicrobial peptides cathelicidin and beta defensin-2 and outcomes in community acquired pneumonia. In hospitalised patients with community acquired pneumonia, vitamin D deficiency but not antimicrobial peptide levels were associated with increased 30-day mortality. Vitamin D was not associated with levels of the antimicrobial peptide cathelicidin or beta defensin-2.

year: 2011

title: Factors affecting employer adoption of drug testing in New Zealand

authors: Haar, Jarrod M.

subjects: employee drug testing

abstract: This paper explores employer attitudes towards drug testing in New Zealand to establish under what conditions adoption may be encouraged or discouraged. A survey of 162 New Zealand employers found that adoption rates of drug testing policies were low at 6 per cent. Exploring predictors of the likelihood of drug testing adoption in the next year found that firms that are more compliant to institutional pressures were more likely to seek adoption, as were firms that perceived positive benefits from adoption. Further, firms that perceived negative effects from drug testing, such as union pressures, were less likely to adopt drug testing in the future. Additionally, the moderating effects of organisational size was explored, and significantly affected likely adoption rates, with larger firms being more influenced by institutional pressures and positive effects. However, there was no significant moderation effect towards negative effects of drug testing, which remained strongly negative irrespective of organisational size.

text: Factors affecting employer adoption of drug testing in New Zealand This paper explores employer attitudes towards drug testing in New Zealand to establish under what conditions adoption may be encouraged or discouraged. A survey of 162 New Zealand employers found that adoption rates of drug testing policies were low at 6 per cent. Exploring predictors of the likelihood of drug testing adoption in the next year found that firms that are more compliant to institutional pressures were more likely to seek adoption, as were firms that perceived positive benefits from adoption. Further, firms that perceived negative effects from drug testing, such as union pressures, were less likely to adopt drug testing in the future. Additionally, the moderating effects of organisational size was explored, and significantly affected likely adoption rates, with larger firms being more influenced by institutional pressures and positive effects. However, there was no significant moderation effect towards negative effects of drug testing, which remained strongly negative irrespective of organisational size.

year: 2007

title: Mihi (Foreword)

authors: Tuaupiki, Jackie Whetumarama

abstract: Mihi of Te Kōtihitihi - Ngā Tuhinga Reo Māori Putanga 3

text: Mihi (Foreword) Mihi of Te Kōtihitihi - Ngā Tuhinga Reo Māori Putanga 3

year: 2016